Article Details

AstraZeneca to show 'exceptional' data on neuromyelitis drug Ultomiris - Morningstar

Retrieved on: 2022-10-12 22:06:23

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to show 'exceptional' data on neuromyelitis drug Ultomiris - Morningstar. View article details on hiswai:

Excerpt

(Alliance News) - AstraZeneca PLC on Wednesday said its subsidiary Alexion Pharmaceuticals Inc, ...

Article found on: www.morningstar.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up